Genzyme Corporate Research Search Genzyme Websites
Patients and FamiliesHealth Care ProfessionalsAbout Genzyme Therapeutics
Fabry Community HomeFabry Community
Health Care Professional Overview
About Fabry Disease
Signs and Symptoms
Genetics of Fabry Disease
Diagnosing Fabry
Disease Monograph
Current Treatments
The Fabry Registry
Genzyme Support
Resources

Angiokeratomas

Renal ImpactCardiac Dysfunction
Cerebrovascular ComplicationsPain
AngiokeratomasHypohidrosis/Anhidrosis
Ophthalmologic FindingsHeat and Cold Intolerance
Gastrointestinal Manifestations 

Angiokeratomas are the most visibly recognizable clinical feature of Fabry disease. These dark red or purple skin lesions (ranging in size from pinpoint to several millimeters in diameter) do not blanch with pressure and are usually distributed on the buttocks, groin, umbilicus, and upper thighs (bathing trunk distribution). Lesions generally appear in adolescence or young adulthood. Angiokeratomas are almost universal in male hemizygotes; they occur in approximately 30% of heterozygous females.[1,2]

Angiokeratomas in the umbilical region

Because angiokeratomas may be concealed by undergarments, their presence can be missed during routine physical examinations.

For a selected list of articles discussing dermatologic manifestations, click here.

References

1. Desnick RJ, Ioannou YA, Eng CM. Alpha-galactosidase A deficiency: Fabry disease. In: The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw Hill, 2001;3733-3774.

2. Menkes DL. Images in neurology. The cutaneous stigmata of Fabry disease: an X-linked phakomatosis associated with central and peripheral nervous system dysfunction. Arch Neurol. 1999;56:487.

Keyword: 
Search In: 
New Page 1
Fabry Voices
""

More Fabry patient profiles
Resources
Medical Information Services
Request Materials
Publications
Events Calendar
Related Links
Fabry Registry

First Symptoms to Diagnosis

Data from the Fabry Registry confirms the large gap between the average age of symptoms onset (10.5) and diagnosis of Fabry disease (28.5). To learn more about the importance of the Fabry Registry click here.

Contact Information
Genzyme Therapeutics
500 Kendall Street
Cambridge, MA 02142
617 768 9000
800 745 4447

Genzyme Europe BV
Gooimeer 10
1411 DD Naarden
The Netherlands
31 35 699 1200
Contact Genzyme


Terms and Conditions of Use | Privacy Policy | © 2003-2008 Genzyme Corporation. All rights reserved.| © Fabr/US/P219/08/05
Genzyme Therapeutics